Welcome to LookChem.com Sign In|Join Free
  • or
6-bromohexanoyl-p-nitrophenylester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

135249-11-5

Post Buying Request

135249-11-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

135249-11-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 135249-11-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,2,4 and 9 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 135249-11:
(8*1)+(7*3)+(6*5)+(5*2)+(4*4)+(3*9)+(2*1)+(1*1)=115
115 % 10 = 5
So 135249-11-5 is a valid CAS Registry Number.

135249-11-5Downstream Products

135249-11-5Relevant academic research and scientific papers

Organocatalytic activation of alkylacetic esters as enolate precursors to react with α,β-unsaturated imines

Hao, Lin,Chen, Shaojin,Xu, Jianfeng,Tiwari, Bhoopendra,Fu, Zhenqian,Li, Tong,Lim, Jieyan,Chi, Yonggui Robin

, p. 4956 - 4959 (2013)

Asymmetric functionalization of alkylacetic esters and their derivatives is traditionally achieved via preformed enolates with chiral auxiliaries. Catalytic versions of such transformations are attractive but challenging. A direct catalytic activation of simple alkylacetic esters via N-heterocyclic carbene organocatalysts to generate chiral enolate intermediates for highly enantioselective reactions is reported.

NITRIC OXIDE DONATING DERIVATIVES OF FLUPROSTENOL

-

Paragraph 0217; 0218, (2018/05/17)

The present invention relates to 15-nitrooxyderivatives of fluprostenol, their use for the treatment of glaucoma and ocular hypertension and formulation containing 15-nitrooxy derivatives of fluprostenol.

NITRIC OXIDE DONATING CARNOSINE COMPOUNDS

-

Page/Page column 23, (2016/05/02)

The present invention relates to nitric oxide donor carnosine derivatives having a great efficacy in reducing elevated intraocular pressure, to processes for their preparation and to their use in the treatment and/or prophylaxis of glaucoma and ocular hyp

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 135249-11-5